One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v130.suppl_1.lba-2.lba-2
Copy DOI Journal: Blood |  Publication Date: Dec 7, 2017 |
 Citations: 14 |
Affiliation: Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Copernicus Memorial Hospital, Medical University of Lodz, AbbVie (United States), University of California, San Diego, Hospital Universitario 12 De Octubre, Jewish General Hospital, Hovon, Academic Medical Center, University Hospital of Montpellier, Medical University of Vienna, Ospedale Niguarda Ca' Granda, Roche (United Kingdom), St James's University Hospital, Memorial Sloan Kettering Cancer Center, Cornell University, University of Calgary, University Hospital Cologne, Australian National UniversityVenetoclax Plus Rituximab Is Superior to Bendamustine Plus Rituximab in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia - Results from Pre-Planned Interim Analysis of the Randomized Phase 3 Murano Study
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
